Technical Analysis for BXRX - Baudax Bio, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Wide Bands | Range Expansion | 0.00% | |
Below Lower BB | Weakness | 0.00% | |
Gapped Down | Weakness | 0.00% | |
Lower Bollinger Band Touch | Weakness | 0.00% | |
Narrow Range Bar | Range Contraction | -21.56% | |
Wide Bands | Range Expansion | -21.56% | |
20 DMA Resistance | Bearish | -15.76% | |
180 Bearish Setup | Bearish Swing Setup | -15.76% | |
Doji - Bullish? | Reversal | -15.76% | |
Wide Bands | Range Expansion | -15.76% |
Free Daily (Stock) Chart Reading
- Earnings date: 03/04/2024
Baudax Bio, Inc. Description
Baudax Bio, Inc., a pharmaceutical company, develops and commercializes products for hospital and other acute care settings. Its lead product candidate is intravenous form of meloxicam, a non-opioid that has completed Phase III clinical trials for the management of moderate to severe pain; and is in the Phase IIIb clinical trials in colorectal surgery and orthopedic surgery patients to assess opioid consumption, pain intensity, and length of hospital stay with associated pharmacoeconomic parameters. The company's early-stage product candidates includes RP1000, an intermediate-acting neuromuscular blocking agent (NMBA) that is in phase I clinical trial; and RP2000, an ultrashort-acting NMBA, which is in pre-clinical trial; and a reversal agent, as well as Dex-IN, a proprietary intranasal formulation of dexmedetomidine. The company was incorporated in 2019 and is based in Malvern, Pennsylvania.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Pharmaceutical Drugs Euphoriants Psychoactive Drugs Clinical Trial Opioids Analgesics Orthopedic Surgery Neurochemistry Ketones Anxiolytics Sodium Channel Blockers Colorectal Surgery Ketamine
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 3.4699 |
52 Week Low | 0.0137 |
Average Volume | 414,987 |
200-Day Moving Average | 0.32 |
50-Day Moving Average | 0.03 |
20-Day Moving Average | 0.02 |
10-Day Moving Average | 0.02 |
Average True Range | 0.00 |
RSI (14) | 35.48 |
ADX | 24.14 |
+DI | 11.64 |
-DI | 27.75 |
Chandelier Exit (Long, 3 ATRs) | 0.01 |
Chandelier Exit (Short, 3 ATRs) | 0.03 |
Upper Bollinger Bands | 0.03 |
Lower Bollinger Band | 0.02 |
Percent B (%b) | -0.07 |
BandWidth | 45.89 |
MACD Line | 0.00 |
MACD Signal Line | 0.00 |
MACD Histogram | 0.0001 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 0.02 | ||||
Resistance 3 (R3) | 0.02 | 0.02 | 0.02 | ||
Resistance 2 (R2) | 0.02 | 0.02 | 0.02 | 0.02 | |
Resistance 1 (R1) | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
Pivot Point | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
Support 1 (S1) | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 |
Support 2 (S2) | 0.01 | 0.01 | 0.01 | 0.01 | |
Support 3 (S3) | 0.01 | 0.01 | 0.01 | ||
Support 4 (S4) | 0.01 |